IP Library Granted Patent US 8,183,374
Granted Patent B2
US 8,183,374 · App. 12/086,633 · Granted May 22, 2012

Piperidine and piperazine derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,183,374
App. No.
12/086,633
Granted
May 22, 2012
Kind
B2
Abstract

Compounds of general formula (Ia): in which R 1 , A 1 , m, X, n, Y and R 3 have any of the meanings given in the specification, have affinity for sigma receptors and are useful in the treatment of disorders of the central nervous system.

Claims (22)

1. A compound of general formula (Ia)

in which:

R 1 represents a phenyl group that is substituted by one, two, or three substituents selected independently from a halogen atom, a cyano group, a halo(1-4C) alkyl group, a (1-6C)alkoxy group, and a halo(1-4C)alkoxy group;

A 1 represents (CH 2 ) m ;

m is 3;

X is CH or N;

n is 2;

Y is O, NR 2 , or S;

R 2 is hydrogen, (1-4C)alkyl or phenyl(1-4C)alkyl, or is as defined for R 3 ; and

R 3 represents a phenyl group that is substituted by one, two, or three substituents selected independently from a halogen atom, a cyano group, a halo(1-4C) alkyl group, a (1-4C)alkoxy group, and a halo(1-4C)alkoxy group;

or a pharmaceutically acceptable salt thereof.

2. A compound as claimed in claim 1 , in which X is N.

3. A compound as claimed in claim 2 , in which Y is O or NR 2 .

4. A compound as claimed in claim 3 , in which Y is NR 2 and R 2 is hydrogen.

5. A compound as claimed in claim 3 , in which Y is O.

6. A compound as claimed in claim 1 , in which R 3 represents 2-fluorophenyl, 4-fluorophenyl, 2-chlorophenyl, 4-chlorophenyl, 4-cyanophenyl, or 2-trifluoromethylphenyl.

7. A compound as claimed in claim 6 , in which R 3 represents a 4-fluorophenyl group.

8. A compound as claimed in claim 1 , which is 1-[2-(2-Fluorophenoxy)ethyl]-4-[3-(4-trifluoromethoxyphenyl)propyl]piperazine, 1-[2-(2-Fluorophenoxy)ethyl]-4-[3-(3,4,5-trimethoxyphenyl)propyl]piperazine, 1-[2-(4-Fluorophenoxy)ethyl]-4-[3-(3,4,5-trimethoxyphenyl)propyl]piperazine, 1-[2-(4-Fluorophenoxy)ethyl]-4-[3-(4-isopropoxyphenyl)propyl]piperazine, or 1-[2-(4-Fluorophenoxy)ethyl]-4-[3-(4-methoxyphenyl)propyl]piperazine, or a pharmaceutically acceptable salt thereof.

9. A compound which is 1-[2-(2-Fluorophenoxy)ethyl]-4-[3-(4-trifluoromethoxyphenyl)propyl]piperazine or a pharmaceutically acceptable salt thereof.

10. A compound which is 1-[2-(2-Fluorophenoxy)ethyl]-4-[3-(4-trifluoromethoxyphenyl)propyl]piperazine dihydrochloride.

11. A compound as claimed in claim 1 , in which R 1 is selected from 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 3,4-difluorophenyl, 3-chlorophenyl, 3-methylphenyl, 2-trifluoromethylphenyl, 3-trifluoromethylphenyl, 4-trifluoromethylphenyl, 2-methoxyphenyl, 3-methoxyphenyl, 4-methoxyphenyl, 4-isopropoxyphenyl, 3,4-dimethoxyphenyl, 2,3,4-trimethoxyphenyl, 3,4,5-trimethoxyphenyl, 2-fluoro-3,4-dimethoxyphenyl, 3-chloro-4-methoxyphenyl, 4-chloro-3-methoxyphenyl, 2-trifluoromethoxyphenyl, 3-trifluoromethoxyphenyl, or 4-trifluoromethoxyphenyl.

12. A compound as claimed in claim 11 , in which R 1 is selected from 4-trifluoromethoxyphenyl, 3,4,5-trimethoxyphenyl, 4-methoxyphenyl, or 4-isopropoxyphenyl.